OATP1B1 and tumour OATP1B3 modulate exposure, toxicity and survival after irinotecan-based chemotherapy
出版年份 2015 全文链接
标题
OATP1B1 and tumour OATP1B3 modulate exposure, toxicity and survival after irinotecan-based chemotherapy
作者
关键词
-
出版物
BRITISH JOURNAL OF CANCER
Volume 112, Issue 5, Pages 857-865
出版商
Springer Nature
发表日期
2015-01-23
DOI
10.1038/bjc.2015.5
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Seeing the forest through the trees: A systematic review of the safety and efficacy of combination chemotherapies used in the treatment of metastatic colorectal cancer
- (2014) Tanios Bekaii-Saab et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Role of hypoxia inducible factor-1α in the regulation of the cancer-specific variant of organic anion transporting polypeptide 1B3 (OATP1B3), in colon and pancreatic cancer
- (2013) Songhee Han et al. BIOCHEMICAL PHARMACOLOGY
- Genetic Determinants of Dabigatran Plasma Levels and Their Relation to Bleeding
- (2013) Guillaume Paré et al. CIRCULATION
- Analysis of UGT1A1*28 genotype and SN-38 pharmacokinetics for irinotecan-based chemotherapy in patients with advanced colorectal cancer: results from a multicenter, retrospective study in Shanghai
- (2013) Xun Cai et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Direct Inhibition and Down-regulation by Uremic Plasma Components of Hepatic Uptake Transporter for SN-38, an Active Metabolite of Irinotecan, in Humans
- (2013) Ken-ichi Fujita et al. PHARMACEUTICAL RESEARCH
- Epigenetic Regulation of Organic Anion Transporting Polypeptide 1B3 in Cancer Cell Lines
- (2013) Satoki Imai et al. PHARMACEUTICAL RESEARCH
- Pharmacogenetics of ABC and SLC transporters in metastatic colorectal cancer patients receiving first-line FOLFIRI treatment
- (2013) Elena De Mattia et al. Pharmacogenetics and Genomics
- Association between UGT1A1*28 Polymorphisms and Clinical Outcomes of Irinotecan-Based Chemotherapies in Colorectal Cancer: A Meta-Analysis in Caucasians
- (2013) Xiang Liu et al. PLoS One
- Genetics is a major determinant of expression of the human hepatic uptake transporter OATP1B1, but not of OATP1B3 and OATP2B1
- (2013) Anne T Nies et al. Genome Medicine
- Identification of a new organic anion transporting polypeptide 1B3 mRNA isoform primarily expressed in human cancerous tissues and cells
- (2012) Miki Nagai et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- A Cancer-Specific Variant of the SLCO1B3 Gene Encodes a Novel Human Organic Anion Transporting Polypeptide 1B3 (OATP1B3) Localized Mainly in the Cytoplasm of Colon and Pancreatic Cancer Cells
- (2012) Nilay Thakkar et al. MOLECULAR PHARMACEUTICS
- The Expression and Function of Organic Anion Transporting Polypeptides in Normal Tissues and in Cancer
- (2011) Amanda Obaidat et al. Annual Review of Pharmacology and Toxicology
- Single nucleotide polymorphisms of ABCC5 and ABCG1 transporter genes correlate to irinotecan-associated gastrointestinal toxicity in colorectal cancer patients: A DMET microarray profiling study
- (2011) Maria Teresa Di Martino et al. CANCER BIOLOGY & THERAPY
- Association of ABCC2 Genotype with Efficacy of First-line FOLFIRI in Japanese Patients with Advanced Colorectal Cancer
- (2011) Yuko Akiyama et al. Drug Metabolism and Pharmacokinetics
- Dose-Dependent Association between UGT1A1*28 Genotype and Irinotecan-Induced Neutropenia: Low Doses Also Increase Risk
- (2010) Z.-Y. Hu et al. CLINICAL CANCER RESEARCH
- Irinotecan pharmacogenomics
- (2010) Sharon Marsh et al. PHARMACOGENOMICS
- An overview of the recent progress in irinotecan pharmacogenetics
- (2010) Yutaka Fujiwara et al. PHARMACOGENOMICS
- Prediction of irinotecan and 5-fluorouracil toxicity and response in patients with advanced colorectal cancer
- (2010) B Glimelius et al. PHARMACOGENOMICS JOURNAL
- Prolonged neutropenia after irinotecan-based chemotherapy in a child with polymorphisms of UGT1A1 and SLCO1B1
- (2009) S Sakaguchi et al. ARCHIVES OF DISEASE IN CHILDHOOD
- Additive effects of drug transporter genetic polymorphisms on irinotecan pharmacokinetics/pharmacodynamics in Japanese cancer patients
- (2009) Kimie Sai et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Irinogenetics: How Many Stars Are There in the Sky?
- (2009) Ron H.J. Mathijssen et al. JOURNAL OF CLINICAL ONCOLOGY
- Comprehensive Pharmacogenetic Analysis of Irinotecan Neutropenia and Pharmacokinetics
- (2009) Federico Innocenti et al. JOURNAL OF CLINICAL ONCOLOGY
- Life-threatening toxicities in a patient with UGT1A1*6/*28 and SLCO1B1*15/*15 genotypes after irinotecan-based chemotherapy
- (2008) Hiroshi Takane et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Overexpression of OATP1B3 Confers Apoptotic Resistance in Colon Cancer
- (2008) W. Lee et al. CANCER RESEARCH
- Clinical and pharmacogenetic factors associated with irinotecan toxicity
- (2008) Dinemarie Kweekel et al. CANCER TREATMENT REVIEWS
- Rapid screening of antineoplastic candidates for the human organic anion transporter OATP1B3 substrates using fluorescent probes
- (2007) Hiroaki Yamaguchi et al. CANCER LETTERS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started